Long-acting, single-dose nanomedicine for battlefield analgesia and neuromuscular recovery during prolonged field care
Active Project Grant Awarded Last action
- Award ID
- HT9425261E460
- Recipient
-
Duquesne University Of The Holy Spirit UEI NGYSJ2L1LZX3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $962,994
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 6% complete
- Place of performance
- Pittsburgh, PA 15282, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Duquesne University $962,994 on September 15, 2026, to develop a long-acting, single-dose nanomedicine for battlefield analgesia and neuromuscular recovery during prolonged field care under the Military Medical Research and Development program (CFDA 12.420). Work is performed in Pittsburgh, Pennsylvania, with a period of performance through September 14, 2028. The project addresses medical solutions for combat casualties by advancing pain management and recovery interventions designed for extended field care environments where evacuation or resupply may be delayed.
Quick answers
Who received award HT9425261E460?
HT9425261E460 was awarded to Duquesne University Of The Holy Spirit by Defense Health Agency (Department of Defense) on September 15, 2026.
How much is award HT9425261E460 worth?
$962,994 has been obligated on HT9425261E460.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award